Immunoblastic Lymphadenopathy - 269 Studies Found
Recruiting |
: A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma : Lymphoma : 2017-01-16 : Drug: plitidepsin Other Name: APLD Aplidine |
Recruiting |
: Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL) : T-cell Lymphoma : 2012-01-20 : Drug: Lenalidomide Lenalidomide |
Recruiting |
: Risk Stratification of Nodal PTCL :
|
Recruiting |
: Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP :
|
Recruiting |
: CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study :
|
Recruiting |
: Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas: a Phase I-II Study :
|
Recruiting |
: Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma :
|
Completed |
: RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas :
: Drug: RAD001 (Everolimus) Phase I Level 1: RAD001 2.5 mg PO daily D1-14 + CHOP Level 2: RAD001 5 mg PO d |
Active, not recruiting |
: Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma :
: Drug: carfilzomib Given IV Other Names: |
Recruiting |
: Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma :
|